|
LSTA | Lisata Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.97 |
| Leverage | 21.32% |
| Market Cap | $ 17.7m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -18.2m |
| Margin | -1982.32% |
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.